Thad Cochran bought Stryker Corporation (NYSE: SYK)
Thad Cochran (R-MS), a U.S. Senator, has disclosed 1 trade in Stryker Corporation (SYK) since 2014, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thad Cochran bought $1,001 - $15,000 of Stryker Corporation (NYSE: SYK) on November 5, 2014. Since that trade, SYK is up +351.83% against the S&P 500 up +345.08%, an outperformance of +6.75%.
Data updated
Thad Cochran's SYK trades vs the price
SYK is up +351.83% since Thad Cochran bought on November 5, 2014, versus +345.08% for the S&P 500.
Performance since this trade
All Thad Cochran SYK trades
Thad Cochran & SYK trading FAQ
Is it legal for Thad Cochran to trade Stryker Corporation (SYK) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Stryker Corporation (SYK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thad Cochran buy SYK?
Thad Cochran disclosed a purchase of $1,001 - $15,000 of Stryker Corporation (SYK) on November 5, 2014, according to public STOCK Act filings.
How has SYK performed since Thad Cochran's trade?
Since Thad Cochran bought SYK on November 5, 2014, the stock is up +351.83%, versus +345.08% for the S&P 500 over the same period, an outperformance of +6.75%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SYK trades?
Quantellect tracks every disclosed congressional trade in Stryker Corporation (SYK) on the Stryker Corporation congressional trading page, which aggregates filings across all members of Congress.
Thad Cochran's SYK tradesAll congressional filings for Stryker CorporationThad Cochran's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.